OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Phillip Ward is the European editor of Applied Clinical Trails.
February 06, 2017
The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.